Figure 3.
Ubiquitin protein D (UBD) expression has a closed relationship with the prognosis of triple-negative breast cancer (TNBC) patients treated with epirubicin chemotherapy. Disease-free survival analyses of 28 TNBC patients treated with epirubicin were compared between the UBD low expression (below the median value) and UBD high expression (above the median value) groups.
Note: The units for the values on x-axis indicated months.
Abbreviations: PFS, progression-free survival; cum, cumulative.